← Evidence map

ReviewOncotarget2012

Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR cascade inhibitors: how mutations can result in therapy resistance and how to overcome resistance.

James A McCubrey et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

178 papers cite itlatest 60 shown

2012
…
2014
2018
2019
2020
2021
2022
2023
2024
2025
2026
this paperpooled itcites it
Full record →Abstract, authors, funding and every citing paper · PMID 23085539